Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohit Oyj Director's Dealing 2019

Jun 3, 2019

3304_dirs_2019-06-03_17441dcc-8fbe-4594-9b85-2cd5e3681679.html

Director's Dealing

Open in viewer

Opens in your device viewer

Disclosure 372510

Biohit Oyj - Managers' transactions

Biohit Plc - Managers' transactions - Söderström

Person subject to the notification requirement

Name: Söderström, Daniela

Position: Other senior manager

Issuer: Biohit Plc

LEI: 74370089ATTSNBXJVT29

Notification type: INITIAL NOTIFICATION

Reference number: 74370089ATTSNBXJVT29_20190603065401_4

Transaction date: 2019-05-29

Instrument type: SHARE

ISIN: FI0009005482

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 25 000 Unit price: 2.2766 EUR

Aggregated transactions

(1): Volume: 25 000 Volume weighted average price: 2.2766 EUR

Biohit Oyj

Semi Korpela

CEO

For additional information:

CEO Semi Korpela,

Biohit Oyj

tel +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com